Clinical Trials and Data Science Conference

Daniel Millar, MBA

• Senior Director, Strategic Business Transformation
• Janssen Research & Development, United States

Deliverables from IMI EU-PEARL and How these will be Sustained Post-Project

Cecile Spiertz, MSc

• Senior Director, External Innovation Clinical Trial Platforms
• Janssen, Netherlands

Protocol Development for Master Protocol Studies – Balancing Structure with Function

Jonathan Mackinnon, PhD

• Associate Director, Medical Writing Services
• Parexel, Spain

Acceptance of Design and Data of Complex Innovative Design Trials by Key Decision-Makers

Christine Fletcher, MSc

• VP/Head, Speciality and Primary Care Statistics
• GlaxoSmithKline, United Kingdom

Panel discussion with Q&A

Olga Kholmanskikh Van Criekingen, MD, PhD

• Clinical assessor
• Federal Agency for Medicines and Health Products, Belgium